Véronique Quillien

Years Active: 2019-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Stéphanie Lhomond, Tony Avril, Nicolas Dejeans, Konstantinos Voutetakis, Dimitrios Doultsinos, Mari McMahon, Raphaël Pineau, Joanna Obacz, Olga Papadodima, Florence Jouan, Heloise Bourien, Marianthi Logotheti, Gwénaële Jégou, Néstor Pallares-Lupon, Kathleen Schmit, Pierre-Jean Le Reste, Amandine Etcheverry, Jean Mosser, Kim Barroso, Elodie Vauléon, Marion Maurel, Afshin Samali, John B Patterson, Olivier Pluquet, Claudio Hetz, Véronique Quillien, Aristotelis Chatziioannou, Éric Chevet
Dual IRE1 RNase functions dictate glioblastoma development. EMBO molecular medicine 14 (2) (2022)
Héloïse Bourien, Véronique Quillien, Florence Godey, Christophe Perrin, Fanny Le Du, Sophie Guillermet, Jérôme Blanchot, Vincent Lavoué, Boris Campillo-Gimenez, Angélique Brunot, Laurence Crouzet, Thibault De la Motte Rouge, Véronique Diéras, Claudia Lefeuvre-Plesse
Impact of EPclin on adjuvant therapeutic decision making and comparison of EPclin to the PREDICT tool. The International journal of biological markers 36 (2) (2021)
Véronique Quillien, Antoine F Carpentier, Alain Gey, Tony Avril, Eric Tartour, Floraly Sejalon, Boris Campillo-Gimenez, Elodie Vauleon
Absolute numbers of regulatory T cells and neutrophils in corticosteroid-free patients are predictive for response to bevacizumab in recurrent glioblastoma patients. Cancer immunology, immunotherapy : CII 68 (6) (2019)

Véronique Quillien.css-eqlu8i{font-size:small;padding-left:4px;}